NextGen Healthcare Stock Forecast, Price & News

NextGen Healthcare's stock was trading at $11.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NXGN shares have increased by 112.1% and is now trading at $23.35.
View which stocks have been most impacted by COVID-19.

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last year. There are currently 1 sell rating, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NextGen Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NXGN, but not buy additional shares or sell existing shares.
View analyst ratings for NextGen Healthcare or view MarketBeat's top 5 stock picks.

Wall Street analysts have given NextGen Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NextGen Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

248 employees have rated NextGen Healthcare CEO Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among NextGen Healthcare's employees.

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, January 27th 2021.
View our earnings forecast for NextGen Healthcare.

NextGen Healthcare, Inc. (NASDAQ:NXGN) posted its quarterly earnings data on Thursday, October, 22nd. The company reported $0.30 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.10. The business had revenue of $140 million for the quarter, compared to the consensus estimate of $133.04 million. NextGen Healthcare had a net margin of 1.80% and a trailing twelve-month return on equity of 11.28%. The company's quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.24 EPS.
View NextGen Healthcare's earnings history.

NextGen Healthcare issued an update on its FY 2021 Pre-Market earnings guidance on Wednesday, January, 13th. The company provided earnings per share guidance of 0.92-0.98 for the period, compared to the Thomson Reuters consensus estimate of $0.89. The company issued revenue guidance of $547-555 million, compared to the consensus revenue estimate of $546.8 million.

12 equities research analysts have issued 12 month price targets for NextGen Healthcare's shares. Their forecasts range from $10.00 to $21.00. On average, they expect NextGen Healthcare's share price to reach $13.86 in the next twelve months. This suggests that the stock has a possible downside of 40.6%.
View analysts' price targets for NextGen Healthcare or view Wall Street analyst' top-rated stocks.

Some companies that are related to NextGen Healthcare include Science Applications International (SAIC), Verint Systems (VRNT), Scientific Games (SGMS), Parsons (PSN), Allscripts Healthcare Solutions (MDRX), Telos (TLS), NetScout Systems (NTCT), Sykes Enterprises (SYKE), Simulations Plus (SLP), Unisys (UIS), Ebix (EBIX), Agilysys (AGYS), Ribbon Communications (RBBN), OneSpan (OSPN) and Tufin Software Technologies (TUFN).
View all of NXGN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

NextGen Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Smith Graham & Co. Investment Advisors LP (1.35%), Strs Ohio (0.07%), State of Alaska Department of Revenue (0.06%) and Investors Research Corp (0.05%). Company insiders that own NextGen Healthcare stock include George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, Lance Rosenzweig and Sheldon Razin.
View institutional ownership trends for NextGen Healthcare.

NXGN stock was sold by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, State of Alaska Department of Revenue, Strs Ohio, and Investors Research Corp. Company insiders that have sold NextGen Healthcare company stock in the last year include George H Bristol, and Lance Rosenzweig.
View insider buying and selling activity for NextGen Healthcare or view top insider-selling stocks.

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NXGN stock can currently be purchased for approximately $23.35.

NextGen Healthcare has a market capitalization of $1.56 billion and generates $540.24 million in revenue each year. The company earns $7.50 million in net income (profit) each year or $0.59 on an earnings per share basis. NextGen Healthcare employs 2,754 workers across the globe.

The official website for NextGen Healthcare is www.nextgen.com.

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at 949-255-2600 or via email at [email protected]